TotalMarketCap

Lucid Diagnostics

LUCDNasdaq United StatesHealth CareMedical/Dental Instruments

Market cap

$79.590 M

$0.39 -12.02%

Close of 6 Nov 2026

As of 6 Nov 2026, Lucid Diagnostics (LUCD) has a market capitalization of $79.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.35M

#3295 by revenue

Earnings

-$58.0M

Loss-making

Shares outstanding

203,243,970

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #74PulmonxLUNG$109.7M
  2. #75NyxoahNYXH$81.3M
  3. #76Lucid DiagnosticsLUCD$79.6M
  4. #77Microbot MedicalMBOT$71.5M
  5. #78SkinHealth SystemsSKIN$67.9M

What if Lucid Diagnostics were worth as much as…

Open the what-if tool →

Gold $28.2T

$138,930.93

Per share 354,778× higher

Bitcoin $1.53T

$7,517.31

Per share 19,196× higher

Apple $5.02T

$24,678.63

Per share 63,020× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Lucid Diagnostics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.